The U.S. Patent and Trademark Office (USPTO) sent out a gentle reminder in the Federal Register to all patent applicants and registered patent practitioners that the export of subject matter (transfer of information) abroad under a foreign filing license is limited to purposes related to the filing of foreign patent applications. The Notice states: Applicants […]

Well, it looks like Margaret Peterlin, Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office (USPTO), has announced that she will be leaving the USPTO in August with plans to pursue employment opportunities in the private sector.  It was probably going to happen some time […]

Just a final reminder of that we ended up having some iPod Shuffles left over from the BIO2008 International Convention.  In the new Patent Baristas iBarista contest, everyone has two new chances to pick up one of the iBarista iPods. Chance 1. For everyone to have an equal chance, I will randomly select a winner […]

AstraZeneca filed an application for a patent term extension (PTE) of the patent term of U.S. Patent No. 5,674,860 under 35 U.S.C. § 156 in the United States Patent and Trademark Office.  They tried to get the extension based the time for FDA review under section 505 of the Federal Food, Drug, and Cosmetic Act […]

Better Living Through Chemistry The World Anti-Doping Agency claims that Italian rider Riccardo Ricco tested positive at the Tour de France after a secret molecule was planted in the blood booster EPO (erythropoietin) during its manufacture. Apparently, Roche included a molecule in the third generation of EPO, called Continuous Erythropoiesis Receptor Activator (CERA), that acted […]

The United States Court of Appeals for the Federal Circuit found in favor of Eisai in Aciphex patent infringement suit against Teva Pharmaceuticals and Dr. Reddy’s Laboratories .  Eisai v. Dr. Reddy’s and Teva (07-1397/98) After Eisai filed infringement actions contesting Teva Pharmaceuticals and Dr. Reddy’s Laboratories’ submission of abbreviated new drug applications (ANDAs) to […]

The business method patent industry is in a state of flux now, due to recent and upcoming Federal Circuit cases, most notably Bilski, and potential federal legislation that could have a profound impact in this area.  Thus, in-house and private practice attorneys who are involved with business method patents are very interested in the effects […]

Jon Gowshall and Ross Walker, patent attorneys with the UK law firm Forresters, announced that they have successfully defended European patent (UK) number 0706376 (to Angiotech Pharmaceuticals Inc and the University of British Columbia), claiming a stent which eluted paclitaxel to prevent restenosis In the case, the House of Lords overturned the first and second […]